Oncternal Therapeutics In...

NASDAQ: ONCT · Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM

Oncternal Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for ONCT stock have an median target of 2, with a low estimate of 2 and a high estimate of 2. The median target predicts an increase of 277.36% from the current stock price of 0.53.

Target Low Average Median High
Price 2 2 2 2
Change 277.36% 277.36% 277.36% 277.36%

Latest Analyst Insight Report

HC Wainwright & Co. has upheld its Buy rating on O... Unlock content with Pro Subscription

Updated Aug 12, 2024

Rating Sep 24
Strong Buy 0
Buy 0
Hold 2
Sell 0
Strong Sell 0
Total 2

Financial Forecast this Year

Revenue This Year
1.92M
from 785K
Increased by 144.6%
Revenue Next Year
600K
from 1.92M
Increased by -68.8%
EPS This Year
-12.43
from -13.43
Increased by 7.4%
EPS Next Year
-10.25
from -12.43
Increased by 17.5%